Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Lynde

Showing results (31-40 of 141) with videos related to

Pageof 15
Sort By:
Journal of Cutaneous Medicine and Surgery|March 19, 2026
Current and Future Management of Chronic Hand Eczema in Canada: Evolving Treatment ParadigmsJensen Yeung, Melinda Gooderham, H Chih-Ho Hong, et al.
Journal of Cutaneous Medicine and Surgery|April 16, 2013
One-year, multicenter, open-label, single-arm study evaluating the safety and effectiveness of etanercept for the treatment of moderate-to-severe plaque psoriasis in a Canadian populationRonald Vender, Charles Lynde, Martin Gilbert, et al.
Pediatric Dermatology|December 28, 2022
Perspectives and knowledge of acne vulgaris among young adolescentsJeffrey Toy, Vincent Wan, Dong Goo Lee, et al.
Journal of Cutaneous Medicine and Surgery|November 15, 2012
Etanercept improves quality of life outcomes and treatment satisfaction in patients with moderate to severe plaque psoriasis in clinical practiceRon Vender, Charles Lynde, Martin Gilbert, et al.
Journal of Cutaneous Medicine and Surgery|August 27, 2009
Work-related lost productivity and its economic impact on Canadian patients with moderate to severe psoriasisBrian Chan, Brigette Hales, Neil Shear, et al.
Journal of Drugs in Dermatology : JDD|December 21, 2019
Truncal Acne: A Neglected EntityJames Q. Del Rosso, Linda Stein-Gold, Charles Lynde, et al.
The Journal of Dermatology|November 8, 2021
Real-world, long-term treatment patterns of commonly used biologics in Canadian patients with moderate-to-severe chronic plaque psoriasisMelinda J Gooderham, Charles Lynde, Irina Turchin, et al.
Journal of Drugs in Dermatology : JDD|March 5, 2025
INDIVIDUAL ARTICLE: NECOM 5: Algorithm for the Treatment and Supportive Management of Targeted Therapy-Related Cutaneous Adverse EventsAda Girnita, Peter Bjerring, Gabriela Lladó Grove, et al.
Journal of Cutaneous Medicine and Surgery|January 19, 2005
The use of alefacept in the treatment of psoriasisRichard Langley, Aditya K Gupta, Yves Poulin, et al.
Journal of Drugs in Dermatology : JDD|September 16, 2017
Treatment of Rosacea With Concomitant Use of Topical Ivermectin 1% Cream and Brimonidine 0.33% Gel: A Randomized, Vehicle-controlled StudyLinda Stein Gold, Kim Papp, Charles Lynde, et al.
Pageof 15

Showing results (31-40 of 141) with videos related to

Sort By:
Pageof 15
Journal of Cutaneous Medicine and Surgery|March 19, 2026
Current and Future Management of Chronic Hand Eczema in Canada: Evolving Treatment ParadigmsJensen Yeung, Melinda Gooderham, H Chih-Ho Hong, et al.
Journal of Cutaneous Medicine and Surgery|April 16, 2013
One-year, multicenter, open-label, single-arm study evaluating the safety and effectiveness of etanercept for the treatment of moderate-to-severe plaque psoriasis in a Canadian populationRonald Vender, Charles Lynde, Martin Gilbert, et al.
Pediatric Dermatology|December 28, 2022
Perspectives and knowledge of acne vulgaris among young adolescentsJeffrey Toy, Vincent Wan, Dong Goo Lee, et al.
Journal of Cutaneous Medicine and Surgery|November 15, 2012
Etanercept improves quality of life outcomes and treatment satisfaction in patients with moderate to severe plaque psoriasis in clinical practiceRon Vender, Charles Lynde, Martin Gilbert, et al.
Journal of Cutaneous Medicine and Surgery|August 27, 2009
Work-related lost productivity and its economic impact on Canadian patients with moderate to severe psoriasisBrian Chan, Brigette Hales, Neil Shear, et al.
Journal of Drugs in Dermatology : JDD|December 21, 2019
Truncal Acne: A Neglected EntityJames Q. Del Rosso, Linda Stein-Gold, Charles Lynde, et al.
The Journal of Dermatology|November 8, 2021
Real-world, long-term treatment patterns of commonly used biologics in Canadian patients with moderate-to-severe chronic plaque psoriasisMelinda J Gooderham, Charles Lynde, Irina Turchin, et al.
Journal of Drugs in Dermatology : JDD|March 5, 2025
INDIVIDUAL ARTICLE: NECOM 5: Algorithm for the Treatment and Supportive Management of Targeted Therapy-Related Cutaneous Adverse EventsAda Girnita, Peter Bjerring, Gabriela Lladó Grove, et al.
Journal of Cutaneous Medicine and Surgery|January 19, 2005
The use of alefacept in the treatment of psoriasisRichard Langley, Aditya K Gupta, Yves Poulin, et al.
Journal of Drugs in Dermatology : JDD|September 16, 2017
Treatment of Rosacea With Concomitant Use of Topical Ivermectin 1% Cream and Brimonidine 0.33% Gel: A Randomized, Vehicle-controlled StudyLinda Stein Gold, Kim Papp, Charles Lynde, et al.
Pageof 15